A community oncology quality initiative: Guideline adherence with adjuvant hormonal therapy in women ≥ age 45 with stages IB-IIIC hormone-sensitive breast cancer

Community Oncology

Volumn 6, Issue 12, 2009, Pages 551-557

  Bosserman, Linda D ^a   Vanderpool, Tracie ^a   Bassi, Nikhil ^a   Emilio, Brandon ^a   Borham, Azah B ^b   Wang, Zhixiao ^b   Chen, Connie ^b  

^a Wilshire Oncology Medical Group Inc   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; AROMATASE INHIBITOR; ESTROGEN RECEPTOR; EXEMESTANE; LETROZOLE; PROGESTERONE RECEPTOR; TAMOXIFEN;

ADULT; AGED; ARTHRALGIA; ARTHRITIS; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER MORTALITY; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG CHOICE; DRUG CONTRAINDICATION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEALTH CARE QUALITY; HOT FLUSH; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; ONCOLOGY; PATIENT COMPLIANCE; POSTMENOPAUSE; PRACTICE GUIDELINE; RETROSPECTIVE STUDY; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 75149129477     PISSN: 15485315     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1548-5315(11)70309-6     Document Type: Article

References (21)

1. Winer EP, Hudis C, Burstein HJ, et al. American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004. J Clin Oncol 2005;23:619-629.
2. Centers for Medicare & Medicaid Services. Compendia 1861 (t)(2) - Anti-cancer. www.cms.hhs.gov/CoverageGenInfo/02-compendia.asp#TopOfPage. Accessed December 8, 2009.
3. Goldhirsch A, Wood WC, Gelber RD, et al. Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007. Ann Oncol 2007;18:1133-1144.
4. National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology. www.nccn.org/professional/physician-gls/PDF/breast.pdf. Accessed November 30, 2009.
5. Panella M, Marchisio S, Di Stanislao F. Reducing clinical variations with clinical pathways: do pathways work? Int J Qual Health Care 2003;15:509-521.
6. Smith TJ, Hillner BE. Ensuring quality cancer care by the use of clinical practice guidelines and critical pathways. J Clin Oncol 2001;19:2886-2897.
7. Centers for Medicare & Medicaid Services. NCCN Compendium Revision Request - CAG-00389. www.cms.hhs.gov/mcd/ncpc-view-document.asp?id=14. Accessed December 8, 2009.
8. UnitedHealthcare Online. Clinical Resources, Cancer-Oncology, NCCN Compendium. www.unitedhealthcareonline.com. Accessed December 8, 2009.
9. Jonat W, Gnant M, Boccardo F, et al. Effectiveness of switching from adjuvant tamoxifen to anastrozole in postmenopausal women with hormone-sensitive early-stage breast cancer: a meta-analysis. Lancet Oncol 2006;7:991-996.
10. Coates AS, Keshaviah A, Thurlimann B, et al. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98. J Clin Oncol 2007;25:486-492.
11. Coombes R, Kilburn L, Snowdon C, et al. Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial. Lancet 2007;369:559-570.
12. Forbes JF, Cuzick J, Buzdar A, et al. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial. Lancet Oncol 2008;9:45-53.
13. Jacobson JO, Neuss MN, McNiff KK, et al. Improvement in oncology practice performance through voluntary participation in the quality oncology practice initiative. J Clin Oncol 2008;26:1893-1898.
14. Centers for Medicare & Medicaid Services. Oncology Demonstration Projects. www.cms.hhs.gov/demoprojectsevalrpts/. Accessed December 8, 2009.
15. Blue Cross Blue Shield of Michigan first health plan to provide reimbursement for participation in QOPI. J Oncol Pract 2008;4:287-288.
16. The Quality Oncology Practice Initiative. QOPI health plan program information. http://qopi.asco.org/Health-Plan-Program.htm. Accessed December 8, 2009.
17. Blue Cross Blue Shield of Michigan. Oncologists and Blue Cross Blue Shield of Michigan partner in national effort to improve cancer care. www.bcbsm.org/pr/pr-08-07-2008-47251.shtml. Accessed December 8, 2009.
18. Bosserman LD. Customizing EMR clickables. Commun Oncol 2008;5:136-138.
19. Western Institutional Review Board. www.wirb.com. Accessed December 8, 2009.
20. Lin NU, Winer EP. Advances in adjuvant endocrine therapy for postmenopausal women. J Clin Oncol 2008;26:798-805.
21. Centers for Medicare & Medicaid Services. E-prescribing measure. www.cms.hhs. gov/ERxIncentive/06-E-Prescribing-Measure.asp. Accessed December 8, 2009.